Alpha Tau Medical Ltd (DRTS) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · United States · ISIN IL0011839383
Alpha Tau Medical Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 USD | 0.00 USD |
| Gross profit | -1.10 m USD | -1.23 m USD |
| Operating income | -36.04 m USD | -42.29 m USD |
| EBIT | -31.44 m USD | -42.29 m USD |
| Net income | -31.75 m USD | -42.63 m USD |
| Diluted EPS – continuing operations | -0.45 USD | -0.53 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Alpha Tau Medical Ltd
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
More stocks
- Aotecar New Energy Technology Co Ltd (002239.SZ)
- Yunnan Hongxiang Yixintang (002727.SZ)
- ICG Enterprise Trust PLC (ICGT.L)
- Energyvision NV (ENRGY.BR)
- LEGALZOOM.COM, INC. (LZ)
- Clearway Energy, Inc. (CWEN)
- Green Cross Corp (006280.KS)
- Tesna Inc (131970.KQ)
- Trainline PLC (TRN.L)
- Tessenderlo Group NV (TESB.BR)
- ASRock Rack Incorporation (7711.TW)
- Finework (Hu Nan) New Energy Technology Co. Ltd. (301232.SZ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.